TrialSync ApS
CVRCVR number43398210Under konkurs
Company financials
Key figures
Updated 10 Jul 2024
- Return on assets
- -36.3%
- Return on equity
- -535.3%
- Current ratio
- 105.9%
- Equity ratio
- 5.6%
Profit and loss
| Reporting period | |
|---|---|
Gross profit | 146,331 |
Operating profit | -40,834 |
Finance income | 63 |
Finance expenses | 474 |
Tax expense | -7,541 |
Profit/loss for the year | -33,704 |
Employees
| Reporting period | |
|---|---|
Avg. employees | 1 |
Personnel costs | 187,165 DKK |
Balance sheet
| Reporting period | |
|---|---|
Cash and cash equivalents | 17,862 |
Current assets | 112,525 |
Total assets | 112,525 |
Equity | 6,296 |
Liabilities | 106,229 |
Current liabilities | 106,229 |
Working capital
| Reporting period | |
|---|---|
Other current receivables | 15,636 |
Trade payables | 45,000 |
Capital and dividend
| Reporting period | |
|---|---|
Contributed capital | 40,000 |
Retained earnings | -33,704 |
Annual report highlights
Official annual report · 2023Open official report
Business and development
Primary activities
Selskabets aktivitet består af at udvikle en digital platform, der strømliner processer, herunder rekruttering af patienter relateret til kliniske forsøgsstudier.
Development in activities and financial affairs
Årets bruttofortjeneste udgør 146.331 kr. Det ordinære resultat efter skat udgør -33.704 kr. Ledelsen anser årets resultat som forventet.
Regnskabsåret har været præget af betydelige opstartsomkostninger, som har resulteret i at selskabets egenkapital udgør mindre end halvdelen af den tegnede kapital. Der er modtaget en støtteerklæring fra selskabets største kapitalejer. Det er ledelsens forventning, at egenkapitalen vil blive reetableret ved fremtidig indtjening.
Commitments and security
Contingent liabilities
4. Eventualposter
Sambeskatning…
Create a free account to see up to 9 years of financial history
Create free account